Large-scale testing (Phase 3)WithdrawnNCT03987750What this trial is testingSafinamide for Levodopa-induced Dyskinesia (PD-LID)Who this might be right forDyskinesia, Drug-InducedParkinson Disease Zambon SpA
Not applicableStudy completedNCT03980444What this trial is testingEffectiveness Basket Wires for the Maintenance of Stone and Pneumatic Probe in the Treatment of Ureteral StonesWho this might be right forUreter Stone Mohammad Sadegh Bagheri Baghdasht 124
Not applicableUnknownNCT04164329What this trial is testingAnesthetic Neurotoxicity: the Association Between General Anesthesia and the Level of Plasma Neurofilament LightWho this might be right forGeneral Anesthetics Toxicity Cardiocentro Ticino 120
Not applicableStudy completedNCT03348956What this trial is testingBiomarkers in Chemotherapy-Induced Peripheral NeurotoxicityWho this might be right forCIPN - Chemotherapy-Induced Peripheral Neuropathy Dartmouth-Hitchcock Medical Center 7
Large-scale testing (Phase 3)Study completedNCT00112996What this trial is testingAlpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for CancerWho this might be right forNeurotoxicityUnspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific M.D. Anderson Cancer Center 244
Not applicableLooking for participantsNCT07357636What this trial is testingLongitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint InhibitorsWho this might be right forSolid TumorImmune-Related Adverse EventsImmunotherapy Toxicity Shantou University Medical College 940
Not applicableStudy completedNCT00305799What this trial is testingHearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid TumorsWho this might be right forNeurotoxicityUnspecified Adult Solid Tumor, Protocol Specific Case Comprehensive Cancer Center 59
Testing effectiveness (Phase 2)Looking for participantsNCT06421675What this trial is testingOutpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple MyelomaWho this might be right forRefractory Multiple Myeloma Ontario Clinical Oncology Group (OCOG) 40
Not applicableStudy completedNCT00263861What this trial is testingNerve Function in Older Diabetic Patients Who Are Undergoing Chemotherapy for Metastatic Solid TumorsWho this might be right forNeurotoxicityUnspecified Adult Solid Tumor, Protocol Specific Case Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT04584983What this trial is testingBilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) AdministrationWho this might be right forBilirubin Encephalopathy The University of Texas Health Science Center, Houston 134
Testing effectiveness (Phase 2)Ended earlyNCT00693472What this trial is testingStudy of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145)Who this might be right forAkathisia, Drug-InducedAntipsychotic AgentsMovement Disorders Merck Sharp & Dohme LLC 46
Not applicableUnknownNCT04446819What this trial is testingCompression Gloves to Reduce Albumin-binding Paclitaxel Induced Peripheral Sensory and Motor Neurotoxicity (REMAINING)Who this might be right forPeripheral Neuropathy Fudan University 70
Post-approval studies (Phase 4)Not Yet RecruitingNCT07344974What this trial is testingHand and Foot Bath for Taxane-Induced Peripheral NeurotoxicityWho this might be right forBreast Cancer Peking University Cancer Hospital & Institute 78
Not applicableStudy completedNCT03342586What this trial is testingUsing a Novel Functional MRI Technique to Evaluate for NeurotoxicityWho this might be right forCentral Nervous System Lymphoma Memorial Sloan Kettering Cancer Center 14
Not applicableStudy completedNCT00755313What this trial is testingEffects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast CancerWho this might be right forBreast CancerChemotherapeutic Agent ToxicityCognitive/Functional Effects+4 more University of California, San Francisco 81
Early research (Phase 1)Study completedNCT00814086What this trial is testingCisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerWho this might be right forChemotherapeutic Agent ToxicityEndometrial AdenocarcinomaFallopian Tube Carcinoma+12 more Gynecologic Oncology Group 23
Early research (Phase 1)Study completedNCT02779140What this trial is testingPhase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632Who this might be right forBotulism National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableStudy completedNCT00437060What this trial is testingBrain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic LeukemiaWho this might be right forChildhood B Acute Lymphoblastic LeukemiaChildhood T Acute Lymphoblastic LeukemiaCognitive Side Effects of Cancer Therapy+4 more Children's Oncology Group 233
Not applicableStudy completedNCT00314080What this trial is testingTreatment of Survivors After Botulism OutbreakWho this might be right forRespiratory FailureBotulism Department of Medical Services Ministry of Public Health of Thailand 18
Testing effectiveness (Phase 2)Ended earlyNCT00069927What this trial is testingAdderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and DepressionWho this might be right forDepressionNeurotoxicityUnspecified Childhood Solid Tumor, Protocol Specific University of South Florida 12